| 08/17 | Direct Relief Delivers Seven-Week Supply of Long-Acting Insulin to Ukraine, Donated by .. | AQ |
| 08/16 | INSIDER BUY : Eli Lilly | MT |
| 08/12 | ELI LILLY AND COMPANY : Ex-dividend day for | FA |
| 08/11 | First Patient Dosed in ALX Oncology's Mid-Stage Trial of Colorectal Cancer Combination .. | MT |
| 08/11 | Lilly Announces Leadership Transition in Human Resources and New Chief Commercial Offic.. | PR |
| 08/11 | Eli Lilly and Company Announces Executive Changes | CI |
| 08/10 | Sermonix to Host Virtual Clinical Update on its ELAINE Phase 2 Clinical Programs | AQ |
| 08/08 | Lilly's Taltz® (ixekizumab) Now Available in New, Citrate-Free Formulation to Reduce In.. | PR |
| 08/08 | Eli Lilly and Company Announces the Availability of a New, Citrate-Free Formulation of .. | CI |
| 08/08 | Eli Lilly May Divert Employment Outside Indiana After US State OKs Abortion Bill | MT |
| 08/06 | Biden team, Eli Lilly condemn new Indiana abortion ban | AQ |
| 08/05 | Goldman Sachs Adjusts Price Target for Eli Lilly and Company to $273 From $277, Maintai.. | MT |
| 08/05 | Eli Lilly Stock Outlook Unchanged After Q2 Update But 'Mixed Elements' to Consider, Gol.. | MT |
| 08/05 | PUMP / DUMP #40 : This week's gainers and losers | |
| 08/05 | WALL STREET STOCK EXCHANGE : Another case of good news is bad news | |
| 08/04 | Cantor Fitzgerald Raises Price Target for Eli Lilly and Company to $360 From $335, Main.. | MT |
| 08/04 | GLOBAL MARKETS LIVE : Bayer, Merck, eBay, MetLife, Eli Lilly... | |
| 08/04 | TRANSCRIPT : Eli Lilly and Company, Q2 2022 Earnings Call, Aug 04, 2022 | CI |
| 08/04 | Eli Lilly Lowers 2022 Profit Outlook on Foreign Exchange Headwinds as Second-Quarter Re.. | MT |
| 08/04 | Lilly Updates Conference Call Start Time for Second-Quarter 2022 Financial Results | PR |
| 08/04 | SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Thursday | MT |
| 08/04 | WALL STREET STOCK EXCHANGE : Still seeing the glass half full | |
| 08/04 | SECTOR UPDATE : Health Care | MT |
| 08/04 | MARKETSCREENER'S WORLD PRESS REVIEW : August 4, 2022 | |
| 08/04 | ELI LILLY AND : Q2 2022 Financial Workbook | PU |
| 08/04 | ELI LILLY AND : Lilly Reports Second-Quarter Financial Results, Highlights Momentum of New.. | PU |
| 08/04 | Eli Lilly Trims FY22 EPS Guidance Amid Weaker Q2 Results | MT |
| 08/04 | Eli Lilly and Company's Q2 Adjusted Earnings, Revenue Fall | MT |
| 08/04 | ELI LILLY AND : Q2 2022 Lilly Press Release | PU |
| 08/04 | LILLY : Q2 Earnings Snapshot | AQ |
| 08/04 | Eli Lilly quarterly profit falls 31% on diabetes drug weakness | RE |
| 08/04 | GUIDANCE : (LLY) ELI LILLY AND COMPANY Expects Fiscal Year 2022 EPS Range $7.90 - $8.05 | MT |
| 08/04 | Lilly Reports Second-Quarter Financial Results, Highlights Momentum of New Medicines an.. | PR |
| 08/04 | Earnings Flash (LLY) ELI LILLY AND COMPANY Posts Q2 Revenue $6.49B | MT |
| 08/04 | Earnings Flash (LLY) ELI LILLY AND COMPANY Reports Q2 EPS $1.25 | MT |
| 08/04 | Eli Lilly and Company Revises Earnings Guidance for the Year 2022 | CI |
| 08/03 | Eli Lilly Seeks US Approval for Direct Sale of COVID-19 Antibody to Healthcare Faciliti.. | MT |
| 08/03 | Eli Lilly to make COVID-19 antibody drug commercially available from August | RE |
| 08/03 | Eli Lilly Says Intends To Make Bebtelovimab Commercially Available For Purchase By U.S... | RE |
| 08/01 | WALL STREET STOCK EXCHANGE : Optimism returns | |
| 07/22 | Lilly's Diabetes Drug Mounjaro Gets EU Medicines Agency Panel's Recommendation | MT |
| 07/21 | Lilly Confirms Date and Conference Call for Second-Quarter 2022 Financial Results Annou.. | PR |
| 07/20 | Auron Therapeutics, Inc. announced that it has received $48 million in funding from a g.. | CI |
| 07/18 | Erasca Working With Eli Lilly in Oncology Clinical Trial | MT |
| 07/18 | Delfi Diagnostics, Inc. announced that it has received $224.999901 million in funding f.. | CI |
| 07/14 | Auron Therapeutics, Inc. announced that it expects to receive funding | CI |
| 07/13 | Triastek Announces Research Collaboration with Lilly to Explore the Application of 3D P.. | CI |
| 07/13 | Goldman Sachs Raises Eli Lilly and Company's Price Target to $277 From $276, Maintains .. | MT |
| 07/12 | WALL STREET STOCK EXCHANGE : Investors are bracing for earnings season | |
| 07/12 | ANALYST RECOMMENDATIONS : Blackrock, Eli Lilly, Hammerson, Mondelez, Twitter... | |
| 07/11 | Guggenheim Raises Price Target for Eli Lilly and Company to $351 From $333, Maintains B.. | MT |
| 07/08 | Morgan Stanley Adjusts Eli Lilly's Price Target to $395 From $369, Reiterates Overweigh.. | MT |
| 07/07 | Barclays Adjusts Eli Lilly and Co.'s Price Target to $355 From $333, Keeps Overweight R.. | MT |
| 07/01 | Pharmaceutical companies still have the upper hand | |
| 06/29 | GLOBAL MARKETS LIVE : Novartis, Tesla, Disney, Sony, Walmart... | |
| 06/29 | Eli Lilly and Company to Supply an Additional 150,000 Doses of Abcellera-Discovered Ant.. | CI |
| 06/29 | WALL STREET STOCK EXCHANGE : Confidence is key | |
| 06/29 | Eli Lilly Bags $275 Million Deal to Supply Additional Doses Of COVID-19 Antibody Drug i.. | MT |
| 06/29 | Eli Lilly to Provide US Government With Additional 150,000 Doses of COVID-19 Treatment .. | MT |
| 06/29 | Lilly will supply an additional 150,000 doses of bebtelovimab to U.S. government in ong.. | PR |
| 06/29 | Eli Lilly and Company Will Supply an Additional 150,000 Doses of Bebtelovimab to U.S. G.. | CI |
| 06/29 | Eli Lilly Gets $275 Million U.S. Pact for Covid-19 Antibody Drug | DJ |
| 06/27 | Lilly Declares Third-Quarter 2022 Dividend | PR |
| 06/27 | Eli Lilly and Company Declares Third-Quarter Dividend for 2022, Payable on September 9,.. | CI |
| 06/27 | Eli Lilly, Innovent's Tyvyt Obtains Approval to Treat Advanced Gastric, Gastroesophagea.. | MT |
| 06/27 | Innovent Biologics, Inc. and Eli Lilly and Company Jointly Announces Approval of TYVYT .. | CI |
| 06/22 | AVEO Pharmaceuticals, Eli Lilly Partner in Clinical Trial to Assess Potential Treatment.. | MT |
| 06/22 | Aveo Pharmaceuticals, Inc. Announces Clinical Trial Collaboration and Supply Agreement .. | CI |
| 06/22 | AVEO Oncology in Collaboration, Supply Agreement With Eli Lilly | DJ |
| 06/21 | Eli Lilly, Innovent's Tyvyt Gets Approval for Treatment of Esophageal Cancer in China | MT |
| 06/21 | Innovent and Lilly Jointly Announce the Approval of TYVYT (sintilimab injection) by Chi.. | CI |
| 06/17 | Sidekick Enters Strategic Collaboration with Lilly to Support Patients with Breast Canc.. | CI |
| 06/14 | TRANSCRIPT : Eli Lilly and Company Presents at Goldman Sachs 43rd Annual Global Healthcare.. | CI |
| 06/14 | Eli Lilly, Incyte Win US FDA Approval For Alopecia Areata Treatment | MT |
| 06/14 | Eli Lilly, Incyte Say FDA Approves Olumiant for Treatment of Alopecia Areata in Adults | MT |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
